Nonconvulsive Status Epilepticus Resulting from Benzodiazepine Withdrawal
- Matthew J. Olnes, MD, PhD;
- Amit Golding, MD, PhD; and
- Peter W. Kaplan, MB, FRCP
- From Johns Hopkins Bayview Medical Center, Baltimore, MD 21224.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
Background: Nonconvulsive status epilepticus is rare but is a treatable cause of impaired consciousness. It can be precipitated by several toxic, metabolic, and epileptic triggers. Benzodiazepine withdrawal, known to precipitate seizures, rarely precipitates nonconvulsive status epilepticus. We describe a patient with nonconvulsive …
This 100-word excerpt has been provided in the absence of an abstract.
RSS Feeds









